nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Tachycardia—Phendimetrazine—obesity	0.00328	0.00582	CcSEcCtD
Pentazocine—Constipation—Methamphetamine—obesity	0.00327	0.0058	CcSEcCtD
Pentazocine—Hyperhidrosis—Phendimetrazine—obesity	0.00324	0.00577	CcSEcCtD
Pentazocine—Agitation—Phenylpropanolamine—obesity	0.00323	0.00574	CcSEcCtD
Pentazocine—Decreased appetite—Benzphetamine—obesity	0.0032	0.00569	CcSEcCtD
Pentazocine—Anorexia—Phendimetrazine—obesity	0.0032	0.00569	CcSEcCtD
Pentazocine—Hallucination—Cimetidine—obesity	0.00318	0.00565	CcSEcCtD
Pentazocine—Tremor—Phentermine—obesity	0.00315	0.0056	CcSEcCtD
Pentazocine—Agitation—Phentermine—obesity	0.00309	0.00549	CcSEcCtD
Pentazocine—Insomnia—Phendimetrazine—obesity	0.00304	0.0054	CcSEcCtD
Pentazocine—Erythema multiforme—Cimetidine—obesity	0.00302	0.00537	CcSEcCtD
Pentazocine—Euphoric mood—Sibutramine—obesity	0.00292	0.00519	CcSEcCtD
Pentazocine—Decreased appetite—Phendimetrazine—obesity	0.00292	0.00519	CcSEcCtD
Pentazocine—Hypertension—Phentermine—obesity	0.0029	0.00516	CcSEcCtD
Pentazocine—Confusional state—Phenylpropanolamine—obesity	0.00289	0.00514	CcSEcCtD
Pentazocine—Constipation—Phendimetrazine—obesity	0.00287	0.0051	CcSEcCtD
Pentazocine—Hepatic function abnormal—Sibutramine—obesity	0.00282	0.00502	CcSEcCtD
Pentazocine—Hypersensitivity—Methamphetamine—obesity	0.00281	0.005	CcSEcCtD
Pentazocine—Dry mouth—Phentermine—obesity	0.0028	0.00497	CcSEcCtD
Pentazocine—Tachycardia—Phenylpropanolamine—obesity	0.0028	0.00497	CcSEcCtD
Pentazocine—Vision blurred—Diethylpropion—obesity	0.00276	0.0049	CcSEcCtD
Pentazocine—Tremor—Diethylpropion—obesity	0.00274	0.00487	CcSEcCtD
Pentazocine—Hypersensitivity—Benzphetamine—obesity	0.00271	0.00482	CcSEcCtD
Pentazocine—Agitation—Diethylpropion—obesity	0.00269	0.00478	CcSEcCtD
Pentazocine—Hypotension—Phenylpropanolamine—obesity	0.00268	0.00476	CcSEcCtD
Pentazocine—Tachycardia—Phentermine—obesity	0.00268	0.00476	CcSEcCtD
Pentazocine—Nystagmus—Topiramate—obesity	0.00264	0.0047	CcSEcCtD
Pentazocine—Diarrhoea—Methamphetamine—obesity	0.00261	0.00464	CcSEcCtD
Pentazocine—Insomnia—Phenylpropanolamine—obesity	0.00259	0.00461	CcSEcCtD
Pentazocine—Agitation—Cimetidine—obesity	0.00256	0.00454	CcSEcCtD
Pentazocine—Dyspnoea—Phenylpropanolamine—obesity	0.00256	0.00454	CcSEcCtD
Pentazocine—Somnolence—Phenylpropanolamine—obesity	0.00255	0.00453	CcSEcCtD
Pentazocine—Euphoric mood—Bupropion—obesity	0.00255	0.00453	CcSEcCtD
Pentazocine—Dizziness—Methamphetamine—obesity	0.00253	0.00449	CcSEcCtD
Pentazocine—Diarrhoea—Benzphetamine—obesity	0.00252	0.00448	CcSEcCtD
Pentazocine—Insomnia—Phentermine—obesity	0.00248	0.00441	CcSEcCtD
Pentazocine—Hepatic function abnormal—Bupropion—obesity	0.00246	0.00438	CcSEcCtD
Pentazocine—Constipation—Phenylpropanolamine—obesity	0.00245	0.00436	CcSEcCtD
Pentazocine—Dizziness—Benzphetamine—obesity	0.00243	0.00433	CcSEcCtD
Pentazocine—Dry mouth—Diethylpropion—obesity	0.00243	0.00433	CcSEcCtD
Pentazocine—Disorientation—Bupropion—obesity	0.00241	0.00428	CcSEcCtD
Pentazocine—Headache—Methamphetamine—obesity	0.00239	0.00425	CcSEcCtD
Pentazocine—Face oedema—Sibutramine—obesity	0.00238	0.00424	CcSEcCtD
Pentazocine—Feeling abnormal—Phenylpropanolamine—obesity	0.00236	0.0042	CcSEcCtD
Pentazocine—Urinary retention—Sibutramine—obesity	0.00235	0.00417	CcSEcCtD
Pentazocine—Constipation—Phentermine—obesity	0.00235	0.00417	CcSEcCtD
Pentazocine—Tachycardia—Diethylpropion—obesity	0.00233	0.00414	CcSEcCtD
Pentazocine—Hyperhidrosis—Diethylpropion—obesity	0.00231	0.0041	CcSEcCtD
Pentazocine—Headache—Benzphetamine—obesity	0.00231	0.0041	CcSEcCtD
Pentazocine—Cramp muscle—Orlistat—obesity	0.0023	0.00408	CcSEcCtD
Pentazocine—Diarrhoea—Phendimetrazine—obesity	0.0023	0.00408	CcSEcCtD
Pentazocine—Confusional state—Cimetidine—obesity	0.00229	0.00407	CcSEcCtD
Pentazocine—Visual disturbance—Bupropion—obesity	0.00227	0.00404	CcSEcCtD
Pentazocine—Anaphylactic shock—Cimetidine—obesity	0.00227	0.00404	CcSEcCtD
Pentazocine—Dizziness—Phendimetrazine—obesity	0.00222	0.00394	CcSEcCtD
Pentazocine—Tachycardia—Cimetidine—obesity	0.00222	0.00394	CcSEcCtD
Pentazocine—Nausea—Benzphetamine—obesity	0.00219	0.00389	CcSEcCtD
Pentazocine—Insomnia—Diethylpropion—obesity	0.00216	0.00384	CcSEcCtD
Pentazocine—Diplopia—Bupropion—obesity	0.00215	0.00383	CcSEcCtD
Pentazocine—Sweating increased—Orlistat—obesity	0.00215	0.00382	CcSEcCtD
Pentazocine—Dyspnoea—Diethylpropion—obesity	0.00213	0.00378	CcSEcCtD
Pentazocine—Somnolence—Diethylpropion—obesity	0.00212	0.00377	CcSEcCtD
Pentazocine—Abdominal discomfort—Orlistat—obesity	0.00211	0.00376	CcSEcCtD
Pentazocine—Eosinophilia—Sibutramine—obesity	0.00211	0.00375	CcSEcCtD
Pentazocine—Hypersensitivity—Phenylpropanolamine—obesity	0.00211	0.00375	CcSEcCtD
Pentazocine—Headache—Phendimetrazine—obesity	0.0021	0.00374	CcSEcCtD
Pentazocine—Face oedema—Bupropion—obesity	0.00208	0.00369	CcSEcCtD
Pentazocine—Irritability—Bupropion—obesity	0.00205	0.00365	CcSEcCtD
Pentazocine—Urinary retention—Bupropion—obesity	0.00205	0.00364	CcSEcCtD
Pentazocine—Constipation—Diethylpropion—obesity	0.00204	0.00363	CcSEcCtD
Pentazocine—Somnolence—Cimetidine—obesity	0.00202	0.00359	CcSEcCtD
Pentazocine—Nausea—Phendimetrazine—obesity	0.00199	0.00354	CcSEcCtD
Pentazocine—Asthenia—Phentermine—obesity	0.00197	0.0035	CcSEcCtD
Pentazocine—Feeling abnormal—Diethylpropion—obesity	0.00197	0.0035	CcSEcCtD
Pentazocine—Constipation—Cimetidine—obesity	0.00194	0.00345	CcSEcCtD
Pentazocine—Cramp muscle—Bupropion—obesity	0.00194	0.00344	CcSEcCtD
Pentazocine—Dizziness—Phenylpropanolamine—obesity	0.0019	0.00337	CcSEcCtD
Pentazocine—Diarrhoea—Phentermine—obesity	0.00188	0.00334	CcSEcCtD
Pentazocine—Feeling abnormal—Cimetidine—obesity	0.00187	0.00333	CcSEcCtD
Pentazocine—Sweating—Sibutramine—obesity	0.00182	0.00324	CcSEcCtD
Pentazocine—Vomiting—Phenylpropanolamine—obesity	0.00182	0.00324	CcSEcCtD
Pentazocine—Dizziness—Phentermine—obesity	0.00181	0.00322	CcSEcCtD
Pentazocine—Sweating increased—Bupropion—obesity	0.00181	0.00322	CcSEcCtD
Pentazocine—Dermatitis—Phenylpropanolamine—obesity	0.00181	0.00321	CcSEcCtD
Pentazocine—Abdominal discomfort—Bupropion—obesity	0.00178	0.00317	CcSEcCtD
Pentazocine—Vomiting—Phentermine—obesity	0.00174	0.0031	CcSEcCtD
Pentazocine—Dermatitis—Phentermine—obesity	0.00173	0.00307	CcSEcCtD
Pentazocine—Headache—Phentermine—obesity	0.00172	0.00305	CcSEcCtD
Pentazocine—Nausea—Phenylpropanolamine—obesity	0.0017	0.00303	CcSEcCtD
Pentazocine—Hypersensitivity—Cimetidine—obesity	0.00167	0.00297	CcSEcCtD
Pentazocine—Visual impairment—Sibutramine—obesity	0.00165	0.00293	CcSEcCtD
Pentazocine—Diarrhoea—Diethylpropion—obesity	0.00163	0.0029	CcSEcCtD
Pentazocine—Nausea—Phentermine—obesity	0.00163	0.0029	CcSEcCtD
Pentazocine—Asthenia—Cimetidine—obesity	0.00163	0.0029	CcSEcCtD
Pentazocine—Euphoric mood—Topiramate—obesity	0.00162	0.00288	CcSEcCtD
Pentazocine—Tinnitus—Sibutramine—obesity	0.00159	0.00283	CcSEcCtD
Pentazocine—Sweating—Bupropion—obesity	0.00159	0.00283	CcSEcCtD
Pentazocine—Dizziness—Diethylpropion—obesity	0.00158	0.00281	CcSEcCtD
Pentazocine—Diarrhoea—Cimetidine—obesity	0.00155	0.00276	CcSEcCtD
Pentazocine—Disorientation—Topiramate—obesity	0.00153	0.00272	CcSEcCtD
Pentazocine—Chills—Sibutramine—obesity	0.00153	0.00272	CcSEcCtD
Pentazocine—Vomiting—Diethylpropion—obesity	0.00152	0.0027	CcSEcCtD
Pentazocine—Dysgeusia—Orlistat—obesity	0.0015	0.00267	CcSEcCtD
Pentazocine—Dermatitis—Diethylpropion—obesity	0.0015	0.00267	CcSEcCtD
Pentazocine—Dizziness—Cimetidine—obesity	0.0015	0.00267	CcSEcCtD
Pentazocine—Headache—Diethylpropion—obesity	0.0015	0.00266	CcSEcCtD
Pentazocine—Hallucination—Bupropion—obesity	0.00148	0.00263	CcSEcCtD
Pentazocine—Muscle spasms—Orlistat—obesity	0.00148	0.00263	CcSEcCtD
Pentazocine—Dysgeusia—Sibutramine—obesity	0.00146	0.00259	CcSEcCtD
Pentazocine—Vision blurred—Orlistat—obesity	0.00145	0.00257	CcSEcCtD
Pentazocine—Visual disturbance—Topiramate—obesity	0.00145	0.00257	CcSEcCtD
Pentazocine—Vomiting—Cimetidine—obesity	0.00144	0.00257	CcSEcCtD
Pentazocine—Visual impairment—Bupropion—obesity	0.00143	0.00255	CcSEcCtD
Pentazocine—Dermatitis—Cimetidine—obesity	0.00143	0.00254	CcSEcCtD
Pentazocine—Muscle spasms—Sibutramine—obesity	0.00143	0.00254	CcSEcCtD
Pentazocine—Headache—Cimetidine—obesity	0.00142	0.00253	CcSEcCtD
Pentazocine—Nausea—Diethylpropion—obesity	0.00142	0.00252	CcSEcCtD
Pentazocine—Erythema multiforme—Bupropion—obesity	0.00141	0.0025	CcSEcCtD
Pentazocine—Vision blurred—Sibutramine—obesity	0.0014	0.00249	CcSEcCtD
Pentazocine—Tremor—Sibutramine—obesity	0.00139	0.00248	CcSEcCtD
Pentazocine—Tinnitus—Bupropion—obesity	0.00139	0.00247	CcSEcCtD
Pentazocine—Flushing—Bupropion—obesity	0.00138	0.00246	CcSEcCtD
Pentazocine—Vertigo—Orlistat—obesity	0.00138	0.00245	CcSEcCtD
Pentazocine—Diplopia—Topiramate—obesity	0.00137	0.00244	CcSEcCtD
Pentazocine—Agitation—Sibutramine—obesity	0.00137	0.00243	CcSEcCtD
Pentazocine—Nausea—Cimetidine—obesity	0.00135	0.0024	CcSEcCtD
Pentazocine—Chills—Bupropion—obesity	0.00134	0.00237	CcSEcCtD
Pentazocine—Vertigo—Sibutramine—obesity	0.00134	0.00237	CcSEcCtD
Pentazocine—Syncope—Sibutramine—obesity	0.00133	0.00237	CcSEcCtD
Pentazocine—Face oedema—Topiramate—obesity	0.00132	0.00235	CcSEcCtD
Pentazocine—Irritability—Topiramate—obesity	0.00131	0.00233	CcSEcCtD
Pentazocine—Loss of consciousness—Sibutramine—obesity	0.00131	0.00232	CcSEcCtD
Pentazocine—Urinary retention—Topiramate—obesity	0.0013	0.00232	CcSEcCtD
Pentazocine—Hypertension—Sibutramine—obesity	0.00128	0.00228	CcSEcCtD
Pentazocine—Dry mouth—Orlistat—obesity	0.00128	0.00227	CcSEcCtD
Pentazocine—Dysgeusia—Bupropion—obesity	0.00127	0.00226	CcSEcCtD
Pentazocine—Anaphylactic shock—Orlistat—obesity	0.00125	0.00223	CcSEcCtD
Pentazocine—Muscle spasms—Bupropion—obesity	0.00125	0.00221	CcSEcCtD
Pentazocine—Dry mouth—Sibutramine—obesity	0.00124	0.0022	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Topiramate—obesity	0.00123	0.00219	CcSEcCtD
Pentazocine—Confusional state—Sibutramine—obesity	0.00122	0.00217	CcSEcCtD
Pentazocine—Vision blurred—Bupropion—obesity	0.00122	0.00217	CcSEcCtD
Pentazocine—Tremor—Bupropion—obesity	0.00121	0.00216	CcSEcCtD
Pentazocine—Anaphylactic shock—Sibutramine—obesity	0.00121	0.00216	CcSEcCtD
Pentazocine—Hyperhidrosis—Orlistat—obesity	0.00121	0.00215	CcSEcCtD
Pentazocine—Shock—Sibutramine—obesity	0.00119	0.00212	CcSEcCtD
Pentazocine—Agitation—Bupropion—obesity	0.00119	0.00212	CcSEcCtD
Pentazocine—Tachycardia—Sibutramine—obesity	0.00118	0.0021	CcSEcCtD
Pentazocine—Eosinophilia—Topiramate—obesity	0.00117	0.00209	CcSEcCtD
Pentazocine—Hyperhidrosis—Sibutramine—obesity	0.00117	0.00208	CcSEcCtD
Pentazocine—Vertigo—Bupropion—obesity	0.00116	0.00207	CcSEcCtD
Pentazocine—Syncope—Bupropion—obesity	0.00116	0.00207	CcSEcCtD
Pentazocine—Anorexia—Sibutramine—obesity	0.00116	0.00206	CcSEcCtD
Pentazocine—Sweating increased—Topiramate—obesity	0.00115	0.00205	CcSEcCtD
Pentazocine—Loss of consciousness—Bupropion—obesity	0.00114	0.00202	CcSEcCtD
Pentazocine—Abdominal discomfort—Topiramate—obesity	0.00114	0.00202	CcSEcCtD
Pentazocine—Insomnia—Orlistat—obesity	0.00113	0.00202	CcSEcCtD
Pentazocine—Hypotension—Sibutramine—obesity	0.00113	0.00202	CcSEcCtD
Pentazocine—Paraesthesia—Orlistat—obesity	0.00113	0.002	CcSEcCtD
Pentazocine—Hypertension—Bupropion—obesity	0.00112	0.00199	CcSEcCtD
Pentazocine—Insomnia—Sibutramine—obesity	0.0011	0.00195	CcSEcCtD
Pentazocine—Decreased appetite—Orlistat—obesity	0.00109	0.00194	CcSEcCtD
Pentazocine—Paraesthesia—Sibutramine—obesity	0.00109	0.00194	CcSEcCtD
Pentazocine—Dyspnoea—Sibutramine—obesity	0.00108	0.00192	CcSEcCtD
Pentazocine—Dry mouth—Bupropion—obesity	0.00108	0.00192	CcSEcCtD
Pentazocine—Somnolence—Sibutramine—obesity	0.00108	0.00192	CcSEcCtD
Pentazocine—Confusional state—Bupropion—obesity	0.00107	0.0019	CcSEcCtD
Pentazocine—Anaphylactic shock—Bupropion—obesity	0.00106	0.00188	CcSEcCtD
Pentazocine—Decreased appetite—Sibutramine—obesity	0.00105	0.00187	CcSEcCtD
Pentazocine—Shock—Bupropion—obesity	0.00104	0.00185	CcSEcCtD
Pentazocine—Constipation—Sibutramine—obesity	0.00104	0.00184	CcSEcCtD
Pentazocine—Feeling abnormal—Orlistat—obesity	0.00103	0.00184	CcSEcCtD
Pentazocine—Tachycardia—Bupropion—obesity	0.00103	0.00183	CcSEcCtD
Pentazocine—Hyperhidrosis—Bupropion—obesity	0.00102	0.00182	CcSEcCtD
Pentazocine—Anorexia—Bupropion—obesity	0.00101	0.00179	CcSEcCtD
Pentazocine—Feeling abnormal—Sibutramine—obesity	0.001	0.00178	CcSEcCtD
Pentazocine—Hypotension—Bupropion—obesity	0.000988	0.00176	CcSEcCtD
Pentazocine—Agranulocytosis—Topiramate—obesity	0.000986	0.00175	CcSEcCtD
Pentazocine—Insomnia—Bupropion—obesity	0.000957	0.0017	CcSEcCtD
Pentazocine—Paraesthesia—Bupropion—obesity	0.00095	0.00169	CcSEcCtD
Pentazocine—Hallucination—Topiramate—obesity	0.000944	0.00168	CcSEcCtD
Pentazocine—Dyspnoea—Bupropion—obesity	0.000943	0.00168	CcSEcCtD
Pentazocine—Somnolence—Bupropion—obesity	0.00094	0.00167	CcSEcCtD
Pentazocine—Hypersensitivity—Orlistat—obesity	0.000924	0.00164	CcSEcCtD
Pentazocine—Decreased appetite—Bupropion—obesity	0.00092	0.00163	CcSEcCtD
Pentazocine—Visual impairment—Topiramate—obesity	0.000914	0.00162	CcSEcCtD
Pentazocine—Constipation—Bupropion—obesity	0.000905	0.00161	CcSEcCtD
Pentazocine—Asthenia—Orlistat—obesity	0.0009	0.0016	CcSEcCtD
Pentazocine—Erythema multiforme—Topiramate—obesity	0.000897	0.00159	CcSEcCtD
Pentazocine—Hypersensitivity—Sibutramine—obesity	0.000894	0.00159	CcSEcCtD
Pentazocine—Pruritus—Orlistat—obesity	0.000887	0.00158	CcSEcCtD
Pentazocine—Tinnitus—Topiramate—obesity	0.000884	0.00157	CcSEcCtD
Pentazocine—Flushing—Topiramate—obesity	0.00088	0.00156	CcSEcCtD
Pentazocine—Feeling abnormal—Bupropion—obesity	0.000872	0.00155	CcSEcCtD
Pentazocine—Asthenia—Sibutramine—obesity	0.000871	0.00155	CcSEcCtD
Pentazocine—Pruritus—Sibutramine—obesity	0.000858	0.00153	CcSEcCtD
Pentazocine—Diarrhoea—Orlistat—obesity	0.000858	0.00152	CcSEcCtD
Pentazocine—Chills—Topiramate—obesity	0.000851	0.00151	CcSEcCtD
Pentazocine—Diarrhoea—Sibutramine—obesity	0.00083	0.00148	CcSEcCtD
Pentazocine—Dizziness—Orlistat—obesity	0.000829	0.00147	CcSEcCtD
Pentazocine—Dysgeusia—Topiramate—obesity	0.000809	0.00144	CcSEcCtD
Pentazocine—Dizziness—Sibutramine—obesity	0.000802	0.00143	CcSEcCtD
Pentazocine—Vomiting—Orlistat—obesity	0.000797	0.00142	CcSEcCtD
Pentazocine—Muscle spasms—Topiramate—obesity	0.000794	0.00141	CcSEcCtD
Pentazocine—Dermatitis—Orlistat—obesity	0.00079	0.0014	CcSEcCtD
Pentazocine—Headache—Orlistat—obesity	0.000785	0.0014	CcSEcCtD
Pentazocine—Hypersensitivity—Bupropion—obesity	0.000779	0.00139	CcSEcCtD
Pentazocine—Vision blurred—Topiramate—obesity	0.000778	0.00138	CcSEcCtD
Pentazocine—Tremor—Topiramate—obesity	0.000774	0.00138	CcSEcCtD
Pentazocine—Vomiting—Sibutramine—obesity	0.000771	0.00137	CcSEcCtD
Pentazocine—Dermatitis—Sibutramine—obesity	0.000764	0.00136	CcSEcCtD
Pentazocine—Headache—Sibutramine—obesity	0.00076	0.00135	CcSEcCtD
Pentazocine—Asthenia—Bupropion—obesity	0.000759	0.00135	CcSEcCtD
Pentazocine—Agitation—Topiramate—obesity	0.000759	0.00135	CcSEcCtD
Pentazocine—Pruritus—Bupropion—obesity	0.000748	0.00133	CcSEcCtD
Pentazocine—Nausea—Orlistat—obesity	0.000745	0.00132	CcSEcCtD
Pentazocine—Vertigo—Topiramate—obesity	0.000742	0.00132	CcSEcCtD
Pentazocine—Syncope—Topiramate—obesity	0.000741	0.00132	CcSEcCtD
Pentazocine—Loss of consciousness—Topiramate—obesity	0.000726	0.00129	CcSEcCtD
Pentazocine—Diarrhoea—Bupropion—obesity	0.000724	0.00129	CcSEcCtD
Pentazocine—Nausea—Sibutramine—obesity	0.000721	0.00128	CcSEcCtD
Pentazocine—Hypertension—Topiramate—obesity	0.000713	0.00127	CcSEcCtD
Pentazocine—Dizziness—Bupropion—obesity	0.000699	0.00124	CcSEcCtD
Pentazocine—Dry mouth—Topiramate—obesity	0.000688	0.00122	CcSEcCtD
Pentazocine—Confusional state—Topiramate—obesity	0.00068	0.00121	CcSEcCtD
Pentazocine—Vomiting—Bupropion—obesity	0.000673	0.0012	CcSEcCtD
Pentazocine—Dermatitis—Bupropion—obesity	0.000666	0.00118	CcSEcCtD
Pentazocine—Shock—Topiramate—obesity	0.000663	0.00118	CcSEcCtD
Pentazocine—Headache—Bupropion—obesity	0.000663	0.00118	CcSEcCtD
Pentazocine—Tachycardia—Topiramate—obesity	0.000658	0.00117	CcSEcCtD
Pentazocine—Hyperhidrosis—Topiramate—obesity	0.000651	0.00116	CcSEcCtD
Pentazocine—Anorexia—Topiramate—obesity	0.000642	0.00114	CcSEcCtD
Pentazocine—Hypotension—Topiramate—obesity	0.00063	0.00112	CcSEcCtD
Pentazocine—Nausea—Bupropion—obesity	0.000628	0.00112	CcSEcCtD
Pentazocine—Insomnia—Topiramate—obesity	0.00061	0.00108	CcSEcCtD
Pentazocine—Paraesthesia—Topiramate—obesity	0.000605	0.00108	CcSEcCtD
Pentazocine—Dyspnoea—Topiramate—obesity	0.000601	0.00107	CcSEcCtD
Pentazocine—Somnolence—Topiramate—obesity	0.000599	0.00106	CcSEcCtD
Pentazocine—Decreased appetite—Topiramate—obesity	0.000586	0.00104	CcSEcCtD
Pentazocine—Constipation—Topiramate—obesity	0.000576	0.00102	CcSEcCtD
Pentazocine—Feeling abnormal—Topiramate—obesity	0.000555	0.000987	CcSEcCtD
Pentazocine—Hypersensitivity—Topiramate—obesity	0.000497	0.000883	CcSEcCtD
Pentazocine—Asthenia—Topiramate—obesity	0.000484	0.000859	CcSEcCtD
Pentazocine—Pruritus—Topiramate—obesity	0.000477	0.000847	CcSEcCtD
Pentazocine—Diarrhoea—Topiramate—obesity	0.000461	0.00082	CcSEcCtD
Pentazocine—Dizziness—Topiramate—obesity	0.000446	0.000792	CcSEcCtD
Pentazocine—Vomiting—Topiramate—obesity	0.000428	0.000762	CcSEcCtD
Pentazocine—Dermatitis—Topiramate—obesity	0.000425	0.000755	CcSEcCtD
Pentazocine—Headache—Topiramate—obesity	0.000422	0.00075	CcSEcCtD
Pentazocine—Nausea—Topiramate—obesity	0.0004	0.000711	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—PARP1—obesity	5.81e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—POMC—obesity	5.8e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRL—obesity	5.78e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPY—obesity	5.77e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—DRD4—obesity	5.76e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOC3—obesity	5.74e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IAPP—obesity	5.74e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STK11—obesity	5.7e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL2—obesity	5.67e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLG—obesity	5.63e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—RHOA—obesity	5.62e-05	0.000129	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGT—obesity	5.62e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—obesity	5.6e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—F2—obesity	5.58e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCB—obesity	5.58e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT2—obesity	5.57e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR1B—obesity	5.57e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CRH—obesity	5.57e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3R1—obesity	5.57e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SDC1—obesity	5.51e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR1—obesity	5.5e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FOXO3—obesity	5.5e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCD—obesity	5.5e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—obesity	5.48e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKR1C3—obesity	5.42e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TCF7L2—obesity	5.4e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS1—obesity	5.4e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT2—obesity	5.38e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—obesity	5.38e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—C3—obesity	5.37e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—DRD2—obesity	5.37e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CD—obesity	5.35e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—obesity	5.34e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS3—obesity	5.33e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTPN1—obesity	5.31e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GCG—obesity	5.31e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPS—obesity	5.28e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GNB3—obesity	5.22e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—F2—obesity	5.19e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCB—obesity	5.19e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DRD1—obesity	5.18e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2C—obesity	5.18e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CD—obesity	5.17e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TYK2—obesity	5.15e-05	0.000118	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—obesity	5.15e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CB—obesity	5.14e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF2—obesity	5.13e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RHOA—obesity	5.11e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGT—obesity	5.1e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GNAS—obesity	5.09e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—obesity	5.08e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRL—obesity	5.07e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3R1—obesity	5.05e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NTRK2—obesity	5.04e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB1—obesity	5.02e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STK11—obesity	5e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOB—obesity	4.98e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—obesity	4.97e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—obesity	4.97e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLG—obesity	4.94e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RHOA—obesity	4.93e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GHRL—obesity	4.91e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PARP1—obesity	4.91e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT2—obesity	4.89e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3R1—obesity	4.88e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DRD4—obesity	4.87e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—obesity	4.86e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FOXO3—obesity	4.82e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—obesity	4.81e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—obesity	4.75e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS1—obesity	4.74e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—obesity	4.73e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FOXO1—obesity	4.72e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2—obesity	4.72e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCB—obesity	4.72e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RPS6KB1—obesity	4.71e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—obesity	4.69e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS3—obesity	4.68e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—obesity	4.67e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR1—obesity	4.65e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNB3—obesity	4.58e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TCF7L2—obesity	4.57e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT2—obesity	4.55e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DRD2—obesity	4.54e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TYK2—obesity	4.52e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—obesity	4.51e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—obesity	4.51e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF2—obesity	4.5e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GCG—obesity	4.49e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTPN1—obesity	4.49e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RHOA—obesity	4.48e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNAS—obesity	4.46e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3R1—obesity	4.43e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCD—obesity	4.38e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—obesity	4.37e-05	9.99e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOB—obesity	4.37e-05	9.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—obesity	4.3e-05	9.82e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—obesity	4.29e-05	9.8e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRL—obesity	4.28e-05	9.79e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—C3—obesity	4.28e-05	9.79e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—obesity	4.26e-05	9.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STK11—obesity	4.22e-05	9.65e-05	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—obesity	4.2e-05	9.61e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—obesity	4.2e-05	9.61e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLG—obesity	4.17e-05	9.54e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—obesity	4.17e-05	9.53e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RHOA—obesity	4.17e-05	9.53e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FOXO1—obesity	4.14e-05	9.46e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RPS6KB1—obesity	4.13e-05	9.45e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT2—obesity	4.13e-05	9.44e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3R1—obesity	4.12e-05	9.43e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—obesity	4.09e-05	9.35e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FOXO3—obesity	4.07e-05	9.32e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS2—obesity	4.07e-05	9.31e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—obesity	4.07e-05	9.3e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—obesity	4.06e-05	9.29e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS1—obesity	4e-05	9.15e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—obesity	3.99e-05	9.11e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—obesity	3.99e-05	9.11e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—obesity	3.97e-05	9.07e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS3—obesity	3.95e-05	9.04e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—obesity	3.95e-05	9.03e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—obesity	3.94e-05	9.01e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNB3—obesity	3.87e-05	8.85e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCD—obesity	3.84e-05	8.78e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TYK2—obesity	3.82e-05	8.73e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—obesity	3.81e-05	8.71e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—obesity	3.81e-05	8.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF2—obesity	3.8e-05	8.69e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RHOA—obesity	3.78e-05	8.65e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNAS—obesity	3.77e-05	8.62e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—obesity	3.76e-05	8.59e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2—obesity	3.76e-05	8.59e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCB—obesity	3.76e-05	8.59e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—C3—obesity	3.75e-05	8.58e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3R1—obesity	3.75e-05	8.56e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BAD—obesity	3.71e-05	8.49e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOB—obesity	3.69e-05	8.44e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—obesity	3.6e-05	8.24e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—obesity	3.6e-05	8.22e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS2—obesity	3.57e-05	8.17e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—obesity	3.57e-05	8.15e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS1—obesity	3.56e-05	8.13e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—obesity	3.52e-05	8.06e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FOXO1—obesity	3.5e-05	8e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—obesity	3.49e-05	7.99e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—obesity	3.49e-05	7.99e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RPS6KB1—obesity	3.49e-05	7.98e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—obesity	3.46e-05	7.92e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—obesity	3.46e-05	7.91e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—obesity	3.45e-05	7.9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—obesity	3.42e-05	7.83e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—obesity	3.4e-05	7.78e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—obesity	3.35e-05	7.66e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—obesity	3.34e-05	7.63e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCB—obesity	3.3e-05	7.54e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2—obesity	3.3e-05	7.54e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—obesity	3.29e-05	7.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT2—obesity	3.29e-05	7.52e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BAD—obesity	3.26e-05	7.45e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCD—obesity	3.25e-05	7.42e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—obesity	3.18e-05	7.26e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—C3—obesity	3.17e-05	7.25e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—obesity	3.16e-05	7.23e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—obesity	3.15e-05	7.21e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—obesity	3.13e-05	7.16e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—obesity	3.13e-05	7.15e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS1—obesity	3.12e-05	7.13e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TYK2—obesity	3.04e-05	6.95e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS2—obesity	3.02e-05	6.9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RHOA—obesity	3.02e-05	6.9e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—obesity	3.01e-05	6.89e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—obesity	3e-05	6.86e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3R1—obesity	2.99e-05	6.83e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—obesity	2.99e-05	6.83e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—obesity	2.99e-05	6.83e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—obesity	2.95e-05	6.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—obesity	2.95e-05	6.75e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—obesity	2.94e-05	6.72e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—obesity	2.93e-05	6.69e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—obesity	2.92e-05	6.68e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—obesity	2.89e-05	6.6e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT2—obesity	2.89e-05	6.6e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—obesity	2.84e-05	6.5e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—obesity	2.82e-05	6.45e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2—obesity	2.79e-05	6.37e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCB—obesity	2.79e-05	6.37e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—obesity	2.77e-05	6.34e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—obesity	2.76e-05	6.3e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTOR—obesity	2.76e-05	6.3e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BAD—obesity	2.75e-05	6.29e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—obesity	2.75e-05	6.28e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—obesity	2.74e-05	6.27e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TYK2—obesity	2.67e-05	6.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—obesity	2.67e-05	6.09e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RHOA—obesity	2.65e-05	6.05e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS1—obesity	2.63e-05	6.02e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—obesity	2.62e-05	5.99e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3R1—obesity	2.62e-05	5.99e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—obesity	2.56e-05	5.85e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—obesity	2.54e-05	5.8e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—obesity	2.52e-05	5.77e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—obesity	2.52e-05	5.76e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—obesity	2.49e-05	5.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—obesity	2.48e-05	5.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—obesity	2.44e-05	5.58e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT2—obesity	2.44e-05	5.58e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MTOR—obesity	2.42e-05	5.53e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—obesity	2.42e-05	5.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—obesity	2.4e-05	5.48e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—obesity	2.34e-05	5.36e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—obesity	2.33e-05	5.33e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—obesity	2.32e-05	5.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.32e-05	5.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—obesity	2.32e-05	5.3e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TYK2—obesity	2.25e-05	5.15e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—obesity	2.24e-05	5.13e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RHOA—obesity	2.24e-05	5.11e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3R1—obesity	2.21e-05	5.06e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—obesity	2.21e-05	5.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—obesity	2.21e-05	5.05e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—obesity	2.13e-05	4.87e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—obesity	2.11e-05	4.82e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—obesity	2.1e-05	4.8e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—obesity	2.04e-05	4.67e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—obesity	2.04e-05	4.67e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTOR—obesity	2.04e-05	4.67e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—obesity	2.04e-05	4.66e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—obesity	1.98e-05	4.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—obesity	1.97e-05	4.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—obesity	1.9e-05	4.34e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—obesity	1.87e-05	4.27e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—obesity	1.87e-05	4.27e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—obesity	1.78e-05	4.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—obesity	1.74e-05	3.97e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—obesity	1.73e-05	3.96e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—obesity	1.73e-05	3.95e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—obesity	1.72e-05	3.94e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—obesity	1.68e-05	3.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—obesity	1.58e-05	3.61e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—obesity	1.49e-05	3.4e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—obesity	1.47e-05	3.37e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—obesity	1.47e-05	3.35e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—obesity	1.46e-05	3.35e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—obesity	1.37e-05	3.14e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—obesity	1.3e-05	2.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—obesity	1.25e-05	2.85e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—obesity	1.2e-05	2.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—obesity	1.1e-05	2.52e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—obesity	1.02e-05	2.33e-05	CbGpPWpGaD
